GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(38391)

  • GN10624 structure
    GN10624Scutellarin
    CAS: 27740-01-8
    Purity: >98.00%

    Scutellarin es un flavonoide con múltiples actividades biológicas.

  • GN10625 structure
    GN106257-Epitaxol
    CAS: 105454-04-4
    Purity: >98.00%
  • GN10627 structure
    GN10627Atractylenolide I
    CAS: 73069-13-3
    Purity: >98.00%
  • GN10629 structure
    GN106295,7-dihydroxychromone
    CAS: 31721-94-5
    Purity: >99.00%

    5,7-dihydroxychromone, venta de la descomposición de flavonoides en cáscaras de cacahuete. Frena el ensanchamiento de raíz en malva silvestre, maíz, cacahuete y trigo

  • GN10632 structure
    GN10632Betulin
    CAS: 473-98-3
    Purity: >98.00%
  • GN10633 structure
    GN10633Scutellarein
    CAS: 529-53-3
    Purity: >99.50%
  • GN10634 structure
    GN10634Myricetin
    CAS: 529-44-2
    Purity: >98.00%

    Myricetin es un flavonoide natural comúnmente encontrado en planteas,posee actividades antioxidantes,antiinflamatorias y antitumorales,y actúa como un nuevo inhibidor de la quinasa quinasa protecia activada por mitógeno(MEK1) y la transformación neoplásica en las células epidérmicas de ratón JB6 P+.

  • GN10639 structure
    GN10639Methyl protodioscin
    CAS: 54522-52-0
    Purity: >98.00%
  • GN10645 structure
    GN10645Jaceosidin
    CAS: 18085-97-7
    Purity: >98%
  • GN10646 structure
    GN10646Engeletin
    CAS: 572-31-6
    Purity: >99.50%
  • GN10647 structure
    GN10647Artemisinine
    CAS: 63968-64-9
    Purity: >98.00%

    Artemisinine es un medicamento antipalúdico de sesquiterpeno lactona extraído de la planta Artemisia annua

  • GN10648 structure
    GN10648Rosmarinic acid
    CAS: 20283-92-5
    Purity: >98.00%

    Rosmarinic acid es un compuesto éster fenólico ampliamente distribuido en las plantas. El ácido rosmarínico posee actividades antivirales, antibacterianas, antiinflamatorias, neuroprotectoras, anticancerígenas, antioxidantes, antiperoxidativas de lípidos y apoptóticas.

  • GN10649 structure
    GN10649Polygalaxanthone III
    CAS: 162857-78-5
    Purity: >99.50%
  • GN10650 structure
    GN10650Ziyuglycoside II
    CAS: 35286-59-0
    Purity: >98.00%
  • GN10652 structure
    GN10652Norisoboldine
    CAS: 23599-69-1
    Purity: >98%
  • GN10654 structure
    GN10654(+)-Corynoline
    CAS: 18797-79-0
    Purity: >98.00%
  • GN10662 structure
    GN10662Cichoric Acid
    CAS: 70831-56-0,6537-80-0
    Purity: >99.50%
  • GN10663 structure
    GN10663Coumarin
    CAS: 91-64-5
    Purity: >99.50%
  • GN10664 structure
    GN10664Honokiol
    CAS: 35354-74-6
    Purity: >98.50%

    Honokiol es un bisfenol natural con múltiples actividades biológicas. Apunta a múltiples moléculas de señalización y presenta efectivas actividades antioxidantes, antiinflamatorias, antiangiogénicas y anticancerígenas. También posee actividades antibacterianas de amplio espectro y anti-virus de inmunodeficiencia humana (VIH).

  • GN10666 structure
    GN10666Isoalantolactone
    CAS: 470-17-7
    Purity: >98.00%
  • GN10667 structure
    GN10667Calycosin
    CAS: 20575-57-9
    Purity: >98.00%

    Calycosin (CA, 7, 3-dihydroxy-4-methoxy isoflavone, C16H12O5) es uno de los flavonoides extraídos de la raíz de astrágalo, también conocido como los fitoestrógenos típicos.

  • GN10668 structure
    GN10668Coenzyme Q10
    CAS: 303-98-0
    Purity: >98.00%
  • GN10669 structure
    GN10669Glucosamine sulfate
    CAS: 29031-19-4
    Purity: >98.00%
  • GN10673 structure
    GN10673Liquiritigenin
    CAS: 578-86-9
    Purity: >99.00%

    Liquiritigenin is a natural flavonoid compound derived from licorice (Glycyrrhiza) that selectively activates estrogen receptor β (ERβ), with a half-maximal effective concentration (EC 50 ) of 36.5nM.